Koers HST Global, Inc. Other OTC
Aandelen
HSTC
US40432E2028
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 3,19 mln. 2,94 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | - |
Nettoschuld 2022 | 75,89K 69,91K | Nettoschuld 2023 | 96,79K 89,17K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-4,34
x | K/w-verhouding 2023 |
-21,8
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 37,71% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,79% | 50,93 mld. | |
-0,56% | 42,12 mld. | |
+49,62% | 42,05 mld. | |
-7,20% | 29,18 mld. | |
+12,59% | 26,02 mld. | |
-21,51% | 18,9 mld. | |
+6,92% | 13,21 mld. | |
+24,91% | 12,17 mld. | |
+29,60% | 12,16 mld. |